Have been topping up in the 5's over the last couple of weeks. $18m market cap is too cheap and shareholder patience will be rewarded IMO.
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress